Back to
FRANKLIN TEMPLETON INC
CTNMShowing 8 of 9 quarters
Position history for
FRANKLIN TEMPLETON INC's holdings in CONTINEUM THERAPEUTICS INC
Yes. Franklin Templeton holds 1,839,227 shares of CTNM (Contineum Therapeutics), worth $30.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Franklin Templeton has held CTNM in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$30.1M
Current Shares
1.8M
Total Value Change
+$6.5M
Total Shares Change
+391,677
Quarter-by-Quarter History
Other major holders of CTNM: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P.